- ►diabetesjournals.org GS Meneilly, CHS McIntosh, RA Pederson, JF … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—Plasma glucose was allowed to fall from a fasting level of ∼11 mmol/l to 5.3 mmol/l in
each study and thereafter was held stable at that level. Plasma insulin levels during both studies
were ∼900 pmol/l. Plasma ... Cited by 20 - Related articles - BL Direct - All 5 versions
MT Behme, J Dupré, TJ McDonald - BMC Endocrine Disorders, 2003 - biomedcentral.com Dose-finding studies were carried out to establish mid range doses for delay of gastric emptying
indicated by postponement of pancreatic polypeptide responses after meals. The selected dose of 0.63
micrograms/kg GLP-1 was ... Cited by 30 - Related articles - Cached - All 7 versions
[CITATION] Endocrine-metabolic function in remission-phase insulin-dependent diabetes …
K Murakami, H Taniguchi, M Tamagawa, K Ejiri, … - Endocrinologia …, 1982 - ncbi.nlm.nih.gov In order to understand the physiological role of endogenous insulin or glucagon in somatostatin
release, isolated rat pancreatic islets were treated with antiinsulin or antiglucagon antiserum in
the presence of physiological ... Cited by 6 - Related articles
- ►endojournals.org JM Egan, GS Meneilly, JF Habener, D Elahi - Journal of Clinical …, 2002 - Endocrine Soc The insulinotropic hormone, glucagon-like peptide-1 (GLP-1), is being examined as a potential new
agent for treatment in type 2 diabetic patients. Whereas the insulinotropic properties of this
peptide are well established, ... Cited by 60 - Related articles - BL Direct - All 8 versions
[CITATION] The honeymoon period or remission phase of Type 1 diabetes, mellitus
NV BOHANNON, M LORENZI, GM GRODSKY, … - Journal of Clinical …, 1982 - Endocrine Soc The effect of iv tolbutamide on endogenous glucagon levels was measured in nine insulin-dependent
diabetic patients chosen because they evidenced no C-peptide response to β-cell secretagogues.
Basal glucagon levels were not ... Cited by 14 - Related articles - All 2 versions
GS Meneilly, CHS McIntosh, RA Pederson, … - … of Gerontology Series …, 2001 - Geron Soc America Results. Glucose values were similar between the control and GLP-1 infusion studies. 120- to
180-minute insulin values appeared to be higher during the GLP-1 infusion study (control, 795 ± 63
pmol/l; GLP-1, 1140 ± 275 pmol/l; ... Cited by 22 - Related articles - All 2 versions
- ►endojournals.org J Dupre, MT Behme, TJ McDonald - Journal of Clinical Endocrinology & …, 2004 - Endocrine Soc Exendin-4 is a reptilian peptide that activates the mammalian receptor for truncated glucagon-like
peptide 1 (tGLP-1) with relatively prolonged actions. Exendin-4 and tGLP-1 can reduce blood glucose
levels by stimulating insulin ... Cited by 48 - Related articles - All 4 versions
GS Meneilly, CHS McIntosh, RA Pederson, JF … - Diabetes Care, 2001 - Am Diabetes Assoc An important cause of elevated glucose levels in elderly patients with diabetes is an alteration in
non–insulin-mediated glucose uptake (NIMGU). Glucagon-like peptide 1 (GLP-1) is an intestinal
insulinotropic hormone. It has been ... Cited by 61 - Related articles - BL Direct - All 5 versions
